Current Cancer Therapy Reviews · 2011 · 142 citations · 53 references
MedicineOncologyRadiation OncologyChemotherapyMedical OncologyMetastasisBrain Metastasis ManagementLeptomeningeal DiseaseMalignant NeoplasmsMetastatic Disease ManagementMetastatic Disease TreatmentRadiation TherapyLeptomeningeal Disease IrradiationLeptomeningeal SpreadMetastatic Disease PalliationNeoplastic DiseaseNeoplastic ProgressionSupportive Cancer CareSystemic Therapy SelectionTherapeutic Efficacy Assessment
As therapeutic options and supportive care for the treatment of neoplastic disease have improved, there has been an associated increase in the incidence of leptomeningeal disease. In this review, the clinical presentation, natural history, diagnostic evaluation, and treatment options for this often devastating sequela of solid tumors, lymphoma, and leukemia will be summarized. The therapeutic efficacy of ionizing radiation, systemic agents, and intrathecal drugs will be examined from the existing literature. Additionally the pathophysiology, which in part defines the therapeutic limitations in approaching this patient population, will be discussed in order to assist in individualized clinical decision making.
53
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Charles E. Geyer, John Forster, Deborah Lindquist et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text
Medicine, Oncology, Pharmacology +17
Michael Glantz, Kurt A. Jaeckle, Marc C. Chamberlain et al. · PubMed · 1999 · 528 citations
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment
James L. Rubenstein, Dan Combs, J. Rosenberg et al. · Blood · 2002 · 422 citations · Full text